AstraZeneca's signs MoU with Indian Diabetes Research Society (RSSDI) to empower 1 Crore Indian Diabetic patients by 2023

Nov 26, 2020

Bangalore (Karnataka) [India], November 26 (ANI/PRNewswire): AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today signed a memorandum of understanding with...

Delhi HC issues notice to NPPA, others on AstraZeneca's plea

Jul 12, 2021

New Delhi [India], July 12 : The Delhi High Court on Monday issued notice to National Pharmaceutical Pricing Authority (NPPA) and others on AstraZeneca...

AstraZeneca gets approval to import breast cancer treatment drug in India

May 03, 2023

AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, on Wednesday announced that it has received approval from the Drug Controller General of India (DCGI)...

Serum Institute to resume COVID-19 vaccine trials in India after DCGI nod

Sep 12, 2020

New Delhi [India], September 12 : Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, ...

DCGI gives nod to Serum Institute to restart phase 2,3 trials for COVID-19 vaccine

Sep 15, 2020

New Delhi [India], September 16 : The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase...

India Pharma 2026: "India well positioned to emerge as global leader in pharma": JP Nadda

Apr 13, 2026

The 9th edition of India Pharma 2026, the flagship event of the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilisers, Government of India,...